Keyphrases
Acetylcholine
27%
Aspirin
23%
Celecoxib
52%
Computational Chemistry
30%
Coursework
46%
COVID-19
100%
Cyclooxygenase-1 (COX-1)
69%
Cyclooxygenase-2
91%
Diabetes
36%
Diclofenac
51%
Dilators
27%
E-learning Tools
27%
Electronic Learning
22%
Endothelium
63%
Endothelium-dependent Vasodilation
46%
Endothelium-derived Hyperpolarizing Factor
32%
First Year
27%
GW0742
49%
Inflammation
43%
Mesenteric Artery
31%
Mortality Prediction
37%
Naproxen
31%
New Therapies
32%
Nitric Oxide
50%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
92%
Nuclear Receptor
56%
Online Self
46%
P2X Receptors
38%
Pancreatic Cancer
46%
Peroxisome Proliferator-activated Receptor
67%
Pharmacology
32%
PPAR Agonists
46%
Prostacyclin
82%
Pulmonary Artery
50%
Pulmonary Hypertension
25%
Rat Aorta
30%
Receptor Antagonist
34%
Receptor for Advanced Glycation End Products
30%
Retrospective Cohort Study
24%
S100P
61%
Science Learning
25%
Self-marking
46%
Thyroid Hormone Receptor
65%
Toll-like
46%
Transrepression
30%
Vascular Dysfunction
25%
Vascular Function
24%
Vasodilation
43%
Worksheet
37%
β-antagonist
30%
Pharmacology, Toxicology and Pharmaceutical Science
15 Hydroxy 11alpha,9alpha Epoxymethanoprosta 5,13 Dienoic Acid
23%
[4 [2 (3 Fluoro 4 Trifluoromethylphenyl) 4 Methyl 5 Thiazolylmethylthio] 2 Methylphenoxy]acetic Acid
49%
Acetylcholine
23%
Adenosine Triphosphate
15%
Advanced Glycation End Product Receptor
30%
Apamin
21%
Beta Adrenergic Receptor Blocking Agent
33%
Cardiovascular Risk
15%
Carvedilol
15%
Celecoxib
53%
Cell Nucleus Receptor
53%
Charybdotoxin
15%
Cyclooxygenase 1
32%
Cyclooxygenase 2
42%
Delta Opiate Receptor Agonist
23%
Delta Opiate Receptor Antagonist
17%
Diabetes Mellitus
27%
Diclofenac
51%
Digestant
15%
Disease
41%
Enzyme-Linked Immunosorbent Assay
26%
Heart Ventricle Hypertrophy
15%
Hormone Receptor Blocking Agent
30%
Hyperthyroidism
15%
Hypoxia-Induced Pulmonary Hypertension
15%
IC50
17%
Inflammation
48%
Lipopolysaccharide
25%
Malignant Neoplasm
40%
Metastasis
18%
Naproxen
31%
Neuropathy
15%
Nitric Oxide
61%
Non-Steroidal Anti-Inflammatory Drug
86%
Pancreas Cancer
61%
Peroxisome Proliferator Activated Receptor
44%
Peroxisome Proliferator Activated Receptor Delta
50%
Potassium Channel
15%
PPAR Agonist
47%
Prostacyclin
51%
Prostaglandin Synthase
22%
Pulmonary Hypertension
41%
Receptor
44%
Side Effect
46%
Spontaneously Hypertensive Rat
15%
Thyroid Hormone
20%
Thyroid Hormone Receptor
34%
Thyroid Hormone Receptor Beta
31%
Toll Like Receptor 4
30%
Vasodilator Agent
19%
Medicine and Dentistry
Acetylcholine
22%
Adenosine Triphosphate
30%
Advanced Glycation End Product Receptor
15%
Apamin
18%
Artery
15%
C Reactive Protein
17%
Cardiovascular System
18%
Carvedilol
15%
Cell Function
16%
Cell Nucleus Receptor
18%
COVID-19
46%
Cyclooxygenase 1
15%
Cyclooxygenase 2
26%
Diabetes
30%
Digestant
15%
Endothelial Cell
16%
Endothelium-Derived Hyperpolarizing Factor
15%
Heart Development
15%
In Vitro
37%
Infection
37%
Influenza A
15%
Influenza B
15%
Innate Immunity
16%
Logistic Regression Analysis
18%
Lung Slice
15%
Lymphocyte
17%
Malignant Neoplasm
25%
Methylglyoxal
15%
Nitric Oxide
30%
Nonsteroid Antiinflammatory Agent
17%
Notch
15%
Pancreas Cancer
30%
Pancreas Disease
15%
Peroxisome Proliferator Activated Receptor
15%
Predictive Modeling
15%
Prostaglandin Synthase
15%
Proteinase Activated Receptor 2
15%
Pulse Rate
15%
Purinergic P2X Receptor
30%
Purinergic P2X1 Receptor
21%
Purinergic P2Y Receptor
15%
Retrospective Cohort Study
17%
Severe Acute Respiratory Syndrome Coronavirus 2
43%
Smooth Muscle Cell
23%
Spontaneously Hypertensive Rat
15%
Thorax Radiography
15%
Toll Like Receptor 4
46%
Transfer of Learning
15%
Vasodilatation
40%
Ventricular Hypertrophy
15%
